Matches in Nanopublications for { ?s ?p "[Among the patients with myelofibrosis, those with ASXL1 lesions were not distinguished from their wild-type counterparts with regard to JAK2 V617F status, exposure to chemotherapy or evolution to leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[Among the patients with myelofibrosis, those with ASXL1 lesions were not distinguished from their wild-type counterparts with regard to JAK2 V617F status, exposure to chemotherapy or evolution to leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP905688.RAXLGUF9C0jzrc33thTtbwap4hLI05vc7eq8dKusgJ9LE130_assertion description "[Among the patients with myelofibrosis, those with ASXL1 lesions were not distinguished from their wild-type counterparts with regard to JAK2 V617F status, exposure to chemotherapy or evolution to leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905688.RAXLGUF9C0jzrc33thTtbwap4hLI05vc7eq8dKusgJ9LE130_provenance.
- NP519234.RADXHlE3z6MUA6YRfuSECiWxxlJROM9xPzRCC3FkeC3g0130_assertion description "[Among the patients with myelofibrosis, those with ASXL1 lesions were not distinguished from their wild-type counterparts with regard to JAK2 V617F status, exposure to chemotherapy or evolution to leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519234.RADXHlE3z6MUA6YRfuSECiWxxlJROM9xPzRCC3FkeC3g0130_provenance.